CollPlant announces six-month study data from its regenerative breast implant program, which could provide a revolutionary alternative to women for aesthetic or medical purposes and aims to address a $3 billion market opportunity Recently received a $2 million development payment from AbbVie Conference call to be held today at 10:00 a.m. U.S. EDT REHOVOT, Israel , March 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced its 2024 financial results and provided a corporate update.

PITTSBURGH--(BUSINESS WIRE)--Wabtec Corporation (NYSE: WAB) announced it will report 2025 first quarter results before the U.S. financial markets open on April 23, 2025. The company will conduct a conference call to discuss those results with analysts and investors at 8:30 a.m. ET the same day. To listen to the call via webcast, visit Wabtec's website at www.WabtecCorp.com and click on “Events & Presentations” in the “Investor Relations” section. An audio replay of the call will be availabl.

48 hour at-home dosing Patient dosing expected in Q2/2025 SALT LAKE CITY , March 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of therapeutics, today announced the initiation of a Phase 3 trial for LPCN 1154 (oral brexanolone) which is in development for the treatment of postpartum depression (PPD). Based on observed comparable exposure of LPCN 1154 and the reference drug established in the pharmacokinetic (PK) bridge study, the company is initiating a phase 3 safety and efficacy study with expected first patient dosed in the second …

Leveraging 20+ Years of Expertise in Technology, Fintech, and Insurtech to Drive Innovation, Market Expansion, and Industry Disruption NEW YORK , March 26, 2025 /PRNewswire/ -- Sharon Rodriguez , CEO of HighPeak and veteran leader in fintech, insurtech, and AI-driven financial solutions, is leading efforts to transform how financial advisors plan for their clients' futures. Under her leadership, HighPeak has quickly become a frontrunner in predictive financial and healthcare cost planning, bringing cutting-edge intelligence to long-term strategies and helping advisors, insurance providers, and benefits managers integrate healthcare costs, longevity insights, and financial plan risk analysis — changing the way future …

WESTMINSTER, Colo. , March 26, 2025 /PRNewswire/ -- Trimble Inc. (NASDAQ: TRMB) (the "Company") today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on March 20, 2025 (the "Notice").

London, United Kingdom--(Newsfile Corp. - March 26, 2025) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company") will hold a conference call on Monday, March 31, 2025, at 4:30 p.m. Eastern time (1:30 p.m.

Up to $2.3 million up front with up to an additional $1.1 million of potential aggregate gross proceeds upon the exercise in full of common stock purchase warrants HENDERSON, Nev. , March 26, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announces today that it has entered into definitive agreements for the purchase and sale of (i) 2,363,636 shares of its common stock to certain directors, executive officers, and certain existing stockholders of the Company (collectively, the "Insiders") at an offering price of $0.55 per share, and (ii) 1,739,087 shares of its …

Company recognized for product and process innovation and culture for the third consecutive year TEANECK, N.J. , March 26, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced that it has been recognized on Fortune's list of "America's Most Innovative Companies 2025".

NEW YORK , March 26, 2025 /PRNewswire/ -- BGC Group, Inc. (Nasdaq: BGC), today announced that it has updated its outlook for the quarter ending March 31, 2025. Updated Outlook BGC reaffirmed its previously stated outlook ranges for revenue and pre-tax Adjusted Earnings for the first quarter of 2025.

DURHAM, N.C., March 26, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the fourth quarter and year ended December 31, 2024, on Friday, March 28, 2025.

AUSTIN, Texas and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands and retailers, today announced the company has hired SaaS and ecommerce veteran Andrew Norman as senior vice president and general manager for EMEA. Norman will lead BigCommerce's go-to-market strategy in EMEA, bringing 25 years experience executing international expansion plans for SaaS technology companies, including 15 years experience in the ecommerce market.

NEW YORK--(BUSINESS WIRE)--Deep Blue Sports + Entertainment today announced the launch of the Women's Sports Audience Intelligence & Monetization (WS/AIM) Service, built in partnership with Precise, creating the first premium private collaboration environment for advertisers to efficiently reach women's sports fans. Genius Sports Limited (“Genius Sports”) (NYSE:GENI) is the platform's first strategic partner, leveraging its proprietary FANHub as the primary platform for digital media activa.

PHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce that the Company will be presenting three posters at the 2025 American Association for Cancer Research (AACR) Annual Meeting taking place from April 25th – 30th at McCormick Place Convention Center, Chicago, IL. The details are listed below. The abstracts will be published in the online Proceedings of the AACR.

SAN FRANCISCO--(BUSINESS WIRE)--Pottery Barn, Pottery Barn Kids and Pottery Barn Teen, portfolio brands of Williams-Sonoma, Inc. (NYSE: WSM), today announce an expansion of the popular collaboration with beloved fashion and lifestyle brand, LoveShackFancy. The expansion includes new collections that build on the popularity of the existing partnership with Pottery Barn Kids and Pottery Barn Teen and includes a debut collaboration with Pottery Barn. The new LoveShackFancy for Pottery Barn collect.

Both Federal Realty Investment Trust (FRT -0.63%) and Realty Income (O -1.15%) are among the most popular real estate investment trusts (REITs) on the stock market. Both companies have quality portfolios, are still managing to grow their business, and pay high-yield dividends.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

PHILADELPHIA, March 26, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Huntington Ingalls Industries, Inc. (NYSE: HII) (“Huntington”) on behalf of the company's shareholders. Click here for additional information: https://kaskelalaw.com/case/huntington-ingalls/ Since September 2024, shares of Huntington's common stock have declined in value from a trading price of over $277.00 per share to a current trading price of below $207.00, a decline of over 25% in value.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NET Power Inc (“Net Power” or the “Company”) (NYSE: NPWR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. (“Merck” or the “Company”) (NYSE: MRK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.